Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Artificial Intelligence in Breast Cancer Screening: Impact of AI-Assisted Single Reading by One Radiologist on Screening Quality Indicators Compared to Standard Double Reading by Two Radiologists Without AI

NCT07075679 is registered in ClinicalTrials.gov with University Hospital Olomouc as lead sponsor.

NCT NCT07075679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07075679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Artificial Intelligence in Breast Cancer Screening: Impact of AI-Assisted Single Reading by One Radiologist on Screening Quality Indicators Compared to Standard Double Reading by Two Radiologists Without AI
Lead sponsor
University Hospital Olomouc
Phase
Not applicable
Overall status
Recruiting
Start date
October 6, 2025
Completion date
October 5, 2028
Enrollment
8,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

artificial intelligence (ai), breast cancer screening, breast cancer screening and diagnosis